NJ State Employees Deferred Compensation Plan’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
2023
Q4
$264K Buy
2023
Q1
Sell
2022
Q4
$204K Hold
2022
Q3
$314K Hold
2022
Q2
$302K Hold
2022
Q1
$370K Hold
2021
Q4
$660K Hold
2021
Q3
$796K Hold
2021
Q2
$727K Hold
2021
Q1
$771K Hold
2020
Q4
$988K Hold
2020
Q3
$747K Hold
2020
Q2
$514K Hold
2020
Q1
$346K Hold
2019
Q4
$580K Buy